Fong et al. suggested five clinical criteria as a clinical risk score including nodal involvement, DFS from the primary to LM < 12 months, number of LM > 1, CEA > 200 ng/mL, the largest tumor >5 cm [8]. Here, CEACAM5 is linked to neoplasm.